Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab With Either Pentostatin or Bendamustine for Relapsed or Refractory Hairy Cell Leukemia
NCT01059786Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Jul 2010
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine, pentostatin in hairy cell leukemia (HCL), sponsored by National Cancer Institute. Started Jul 2010; status: active, not recruiting.
02
Drugs
bendamustinepentostatin
03
Conditions
hairy cell leukemia (HCL)
Beyond the preview
Go deeper on NCT01059786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059786.